MedTrace Logo

Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol

NCT03245554 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-04-09

No results posted yet for this study

Summary

To research the effect of propranolol on the proliferation and apoptosis of gastrointestinal cancer.

Conditions

Interventions

DRUG

Propranolol

0 or 1 were generated by using Random software. The patient entered the placebo group if number was 0; if the random number generated was 1, then entered the propranolol group.

Sponsors & Collaborators

  • Central South University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03245554 on ClinicalTrials.gov